90002793 - CELULARITY

Information

  • Trademark
  • 90002793
  • Serial Number
    90002793
  • Registration Number
    6260135
  • Filing Date
    June 15, 2020
    4 years ago
  • Registration Date
    February 02, 2021
    4 years ago
  • Transaction Date
    November 04, 2022
    2 years ago
  • Status Date
    February 02, 2021
    4 years ago
  • Published for Opposition Date
    November 17, 2020
    4 years ago
  • Location Date
    February 02, 2021
    4 years ago
  • First Use Anywhere Date
    December 06, 2018
    6 years ago
  • First Use In Commerce Date
    December 06, 2018
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LINERO GUARDA, GERARDO
  • Attorney Docket Number
    CLTY0512US2
    Attorney Name
    Camille M. Miller
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
4000
Mark Identification
CELULARITY
Case File Statements
  • GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen;biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
  • GS0011: bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
Case File Event Statements
  • 1/12/2022 - 3 years ago
    18 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 2/2/2021 - 4 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/17/2020 - 4 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/17/2020 - 4 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/28/2020 - 4 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/8/2020 - 4 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/8/2020 - 4 years ago
    12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/8/2020 - 4 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/9/2020 - 4 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/16/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/15/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/15/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/7/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/7/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/7/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/5/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/14/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/18/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP